| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 5-diphosphoinositol pentakisphosphate 1-kinase activity | 6.54e-05 | 2 | 162 | 2 | GO:0033857 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 3-kinase activity | 3.88e-04 | 4 | 162 | 2 | GO:0052724 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 1-kinase activity | 3.88e-04 | 4 | 162 | 2 | GO:0052723 | |
| GeneOntologyMolecularFunction | epidermal growth factor receptor activity | 3.88e-04 | 4 | 162 | 2 | GO:0005006 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | HSP90AB4P EP400 HSPA4L HELQ IFIH1 KIF9 ABCA5 ATF7IP ATP6V0A4 MACF1 KIF3C MORC3 DNAH6 HSP90AB3P | 4.94e-04 | 614 | 162 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | diphosphoinositol pentakisphosphate kinase activity | 6.44e-04 | 5 | 162 | 2 | GO:0000829 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate kinase activity | 6.44e-04 | 5 | 162 | 2 | GO:0000828 | |
| GeneOntologyMolecularFunction | inositol-1,3,4,5,6-pentakisphosphate kinase activity | 6.44e-04 | 5 | 162 | 2 | GO:0000827 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 5-kinase activity | 6.44e-04 | 5 | 162 | 2 | GO:0000832 | |
| GeneOntologyCellularComponent | multivesicular body lumen | 1.34e-05 | 7 | 154 | 3 | GO:0097486 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 2.99e-05 | 164 | 154 | 8 | GO:0098982 | |
| GeneOntologyCellularComponent | late endosome lumen | 6.20e-05 | 11 | 154 | 3 | GO:0031906 | |
| GeneOntologyCellularComponent | postsynaptic density | ROCK2 ANK2 KALRN ASIC1 NLGN4Y PCLO MAGI2 PTPRO MACF1 DMD EPB41L1 | 5.29e-04 | 451 | 154 | 11 | GO:0014069 |
| GeneOntologyCellularComponent | costamere | 5.45e-04 | 22 | 154 | 3 | GO:0043034 | |
| Domain | Aspartic_peptidase_N | 1.81e-05 | 7 | 152 | 3 | IPR012848 | |
| Domain | A1_Propeptide | 1.81e-05 | 7 | 152 | 3 | PF07966 | |
| Domain | Aspartic_peptidase_A1 | 6.08e-05 | 10 | 152 | 3 | IPR001461 | |
| Domain | PEPTIDASE_A1 | 6.08e-05 | 10 | 152 | 3 | IPR033121 | |
| Domain | Asp | 6.08e-05 | 10 | 152 | 3 | PF00026 | |
| Domain | PEPTIDASE_A1 | 6.08e-05 | 10 | 152 | 3 | PS51767 | |
| Domain | RBM39_linker | 6.58e-05 | 2 | 152 | 2 | IPR029123 | |
| Domain | RBM39_SF | 6.58e-05 | 2 | 152 | 2 | IPR006509 | |
| Domain | RBM39linker | 6.58e-05 | 2 | 152 | 2 | PF15519 | |
| Domain | - | 1.10e-04 | 12 | 152 | 3 | 2.40.70.10 | |
| Domain | ASP_PROTEASE | 1.10e-04 | 12 | 152 | 3 | PS00141 | |
| Domain | Aspartic_peptidase_AS | 1.42e-04 | 13 | 152 | 3 | IPR001969 | |
| Domain | RGM_N | 1.96e-04 | 3 | 152 | 2 | IPR010536 | |
| Domain | RGM_C | 1.96e-04 | 3 | 152 | 2 | PF06534 | |
| Domain | RGM_N | 1.96e-04 | 3 | 152 | 2 | PF06535 | |
| Domain | RGM_C | 1.96e-04 | 3 | 152 | 2 | IPR009496 | |
| Domain | Peptidase_aspartic_dom | 3.30e-04 | 17 | 152 | 3 | IPR021109 | |
| Domain | DOCK_N | 6.47e-04 | 5 | 152 | 2 | PF16172 | |
| Domain | DOCK_N | 6.47e-04 | 5 | 152 | 2 | IPR032376 | |
| Domain | Spectrin | 8.30e-04 | 23 | 152 | 3 | PF00435 | |
| Domain | ACTININ_2 | 8.30e-04 | 23 | 152 | 3 | PS00020 | |
| Domain | ACTININ_1 | 8.30e-04 | 23 | 152 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 8.30e-04 | 23 | 152 | 3 | IPR001589 | |
| Domain | FF_domain | 9.66e-04 | 6 | 152 | 2 | IPR002713 | |
| Domain | FF | 9.66e-04 | 6 | 152 | 2 | PS51676 | |
| Domain | FF | 9.66e-04 | 6 | 152 | 2 | PF01846 | |
| Domain | FF | 9.66e-04 | 6 | 152 | 2 | SM00441 | |
| Domain | Acid_Pase_AS | 9.66e-04 | 6 | 152 | 2 | IPR033379 | |
| Domain | - | 9.77e-04 | 93 | 152 | 5 | 1.10.533.10 | |
| Domain | DEATH-like_dom | 1.29e-03 | 99 | 152 | 5 | IPR011029 | |
| Domain | HIS_ACID_PHOSPHAT_2 | 1.35e-03 | 7 | 152 | 2 | PS00778 | |
| Domain | HIS_ACID_PHOSPHAT_1 | 1.35e-03 | 7 | 152 | 2 | PS00616 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 7926498 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 9561228 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 21455714 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 19800305 | ||
| Pubmed | Human pepsinogen A (PGA): an informative gene complex located at 11q13. | 9.92e-08 | 3 | 162 | 3 | 1968039 | |
| Pubmed | Family and population studies on the human pepsinogen A multigene family. | 9.92e-08 | 3 | 162 | 3 | 2566575 | |
| Pubmed | Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. | 9.92e-08 | 3 | 162 | 3 | 19890696 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 6774973 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 6300126 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 24004680 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 23034090 | ||
| Pubmed | Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A. | 9.92e-08 | 3 | 162 | 3 | 3554488 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 23521833 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 3017318 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 9855083 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 2478370 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 3815274 | ||
| Pubmed | Pepsinogens: physiology, pharmacology pathophysiology and exercise. | 9.92e-08 | 3 | 162 | 3 | 10675278 | |
| Pubmed | Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11. | 9.92e-08 | 3 | 162 | 3 | 3839486 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 3467902 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 4586732 | ||
| Pubmed | Genomic structure and evolution of the human pepsinogen A multigene family. | 9.92e-08 | 3 | 162 | 3 | 2892778 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 24383519 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 1455184 | ||
| Pubmed | Hypomethylation and expression of pepsinogen A genes in the fundic mucosa of human stomach. | 9.92e-08 | 3 | 162 | 3 | 2831884 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 1812762 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 7923573 | ||
| Pubmed | An aspartic proteinase expressed in the yolk sac and neonatal stomach of the mouse. | 9.92e-08 | 3 | 162 | 3 | 11566730 | |
| Pubmed | The effect of acute and chronic protein loading on urinary pepsinogen A excretion. | 9.92e-08 | 3 | 162 | 3 | 1956484 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 22992016 | ||
| Pubmed | Gastric chief cell-specific transcription of the pepsinogen A gene. | 9.92e-08 | 3 | 162 | 3 | 8504820 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 20428942 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 9525001 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 7886402 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 21547904 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 24170207 | ||
| Pubmed | Relationships between the human pepsinogen DNA and protein polymorphisms. | 9.92e-08 | 3 | 162 | 3 | 3014868 | |
| Pubmed | The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. | 9.92e-08 | 3 | 162 | 3 | 2799289 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 19872561 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 8053437 | ||
| Pubmed | Immunoblot technique to visualise serum pepsinogen A isozymogen patterns. | 9.92e-08 | 3 | 162 | 3 | 2229438 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 25314140 | ||
| Pubmed | Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A. | 9.92e-08 | 3 | 162 | 3 | 8244094 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 21407214 | ||
| Pubmed | Pepsinogen I/II ratio is related to glucose, triacylglycerol, and uric acid levels. | 9.92e-08 | 3 | 162 | 3 | 22304859 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 8038355 | ||
| Pubmed | Human pepsinogen A isozymogen patterns in serum and gastric mucosa. | 9.92e-08 | 3 | 162 | 3 | 2227273 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 24125879 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 8751234 | ||
| Pubmed | Serum pepsinogen test for early detection of gastric cancer in a European country. | 9.92e-08 | 3 | 162 | 3 | 21989121 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 9797498 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 3780036 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 2901984 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 2032552 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 9061458 | ||
| Pubmed | Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis. | 9.92e-08 | 3 | 162 | 3 | 12588289 | |
| Pubmed | Gastric cancer detection using gastric juice pepsinogen and melanoma-associated gene RNA. | 9.92e-08 | 3 | 162 | 3 | 23897256 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 8540382 | ||
| Pubmed | The role of serum pepsinogen in the detection of gastric cancer. | 9.92e-08 | 3 | 162 | 3 | 20981206 | |
| Pubmed | Detection of pepsinogen in the neonatal lung and stomach by immunohistochemistry. | 9.92e-08 | 3 | 162 | 3 | 21970995 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 17379991 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | THOC1 ROCK2 UBR1 FILIP1 GBF1 ATR EP400 RALGAPB ARHGAP35 PRPF40A PHC2 RBM25 EGFR BRPF1 KMT2A CNOT3 SOS1 | 1.44e-07 | 774 | 162 | 17 | 15302935 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | THOC1 MCMBP GBF1 HSP90AB4P ATR RTCB HSPA4L PUF60 PCLO PPIL4 CMYA5 LANCL2 PRPF40A RBM39 EHD4 LRPPRC RBM25 GCLC AGK KIF3C PRKCSH ATIC CHTOP | 2.17e-07 | 1425 | 162 | 23 | 30948266 |
| Pubmed | THOC1 DOCK2 DOCK4 HSPA4L PUF60 PPIL4 ARHGAP35 RBM39 RBM25 MACO1 BRPF1 AGK KMT2A TNKS PRKCSH DMD PPIP5K2 SOS1 | 3.12e-07 | 916 | 162 | 18 | 32203420 | |
| Pubmed | Transcription factor SOX2 up-regulates stomach-specific pepsinogen A gene expression. | 3.95e-07 | 4 | 162 | 3 | 17136346 | |
| Pubmed | Serum pepsinogen I/II ratio is correlated with albuminuria in patients with type 2 diabetes. | 3.95e-07 | 4 | 162 | 3 | 23047493 | |
| Pubmed | Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development. | 3.95e-07 | 4 | 162 | 3 | 11915945 | |
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 8322031 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 12698190 | ||
| Pubmed | ROCK2 MCMBP RTCB ASIC1 PUF60 PPIL4 SYNC RBM23 RBM39 EHD4 RBM25 TXNL4A AP1B1 AGK CHTOP | 4.64e-07 | 653 | 162 | 15 | 33742100 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | ROCK2 HSP90AB4P RTCB HSPA4L PRPF40A RBM39 EHD4 GTF2F1 RBM25 AP1B1 MACF1 SMARCD2 EXOG PRKCSH DNAH6 CHTOP HSP90AB3P | 5.07e-07 | 847 | 162 | 17 | 35235311 |
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 8.75e-07 | 69 | 162 | 6 | 28481362 | |
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 22066020 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ROCK2 MCMBP GBF1 RTCB HSPA4L PUF60 COG7 USP25 SHMT1 QRICH1 CMYA5 EHD4 GTF2F1 AP1B1 UBE3A GCLC MACF1 N4BP1 PRKCSH ATIC LRBA EPB41L1 | 1.21e-06 | 1455 | 162 | 22 | 22863883 |
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 1.44e-06 | 170 | 162 | 8 | 16159877 | |
| Pubmed | Repulsive guidance molecule is a structural bridge between neogenin and bone morphogenetic protein. | 1.96e-06 | 6 | 162 | 3 | 25938661 | |
| Pubmed | ANK2 KALRN USP25 SYNC QRICH1 CMYA5 USP9Y SKIL LRP1B CFAP298 MAGI2 UBE3A ARID5B MACF1 TNKS ATIC MORC3 LRBA CNOT3 SOS1 | 2.50e-06 | 1285 | 162 | 20 | 35914814 | |
| Pubmed | ROCK2 ANK2 HSPA4L PCDHGA7 PCLO STOX1 MYLK2 EHD4 LRPPRC BMPR1A PHF20L1 GCLC VPS13A MARF1 KMT2A MACF1 SMARCD2 DMD PPIP5K2 SCIMP DNAH6 | 3.87e-06 | 1442 | 162 | 21 | 35575683 | |
| Pubmed | Glucose metabolism induced by Bmp signaling is essential for murine skeletal development. | 5.46e-06 | 8 | 162 | 3 | 30446646 | |
| Pubmed | THOC1 MCMBP ATR EP400 PUF60 PPIL4 QRICH1 PRPF40A PHC2 METTL14 GTF2F1 RBM25 UBE3A KMT2A SMARCD2 ATIC CHTOP | 5.70e-06 | 1014 | 162 | 17 | 32416067 | |
| Pubmed | 7.34e-06 | 151 | 162 | 7 | 17043677 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ANK2 NEBL EP400 RTCB PUF60 ARHGAP35 PRPF40A RBM39 CLMN ATF7IP KMT2A MACF1 PRR14L ATIC LRBA CHTOP | 8.35e-06 | 934 | 162 | 16 | 33916271 |
| Pubmed | 9.69e-06 | 104 | 162 | 6 | 31365120 | ||
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | MCMBP NEBL PUF60 COG7 PGBD1 SKIL HELQ RBM23 RBM39 ZBTB24 KIF9 ACCS PRKCSH DMD | 1.08e-05 | 742 | 162 | 14 | 26871637 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | THOC1 EP400 RTCB KALRN PUF60 PPIL4 ARHGAP35 USP9Y PRPF40A RBM39 PHC2 LRPPRC RBM25 PTPRO AGK MACF1 PPIP5K2 | 1.32e-05 | 1082 | 162 | 17 | 38697112 |
| Pubmed | 1.39e-05 | 304 | 162 | 9 | 32235678 | ||
| Pubmed | 1.51e-05 | 234 | 162 | 8 | 36243803 | ||
| Pubmed | 1.59e-05 | 11 | 162 | 3 | 17003112 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | EP400 RTCB ACTR5 HSPA4L PHC2 LRPPRC TXNL4A KMT2A PRKCSH CHTOP | 1.75e-05 | 394 | 162 | 10 | 27248496 |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 19789263 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 18981179 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 33159041 | ||
| Pubmed | EGF receptor uses SOS1 to drive constitutive activation of NFκB in cancer cells. | 2.16e-05 | 2 | 162 | 2 | 25071181 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 23340173 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 28263981 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 20007531 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 35205374 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 19954019 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 33441708 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 23205726 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | SPDYE17 SPDYE10 SPDYE9 SPDYE12 SPDYE11 SPDYE13 SPDYE15 SPDYE8 SPDYE14 | 6.50e-07 | 271 | 164 | 9 | chr7q11 |
| GeneFamily | X-linked mental retardation|RNA helicases | 1.52e-03 | 11 | 97 | 2 | 1168 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZSCAN12 ZNF267 ZNF226 ZBTB24 ZNF705D ZNF12 RBAK ZNF75A ZNF615 ZNF705B ZNF649 | 1.60e-03 | 718 | 97 | 11 | 28 |
| GeneFamily | Fibronectin type III domain containing | 1.71e-03 | 160 | 97 | 5 | 555 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 1.82e-03 | 12 | 97 | 2 | 756 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ROCK2 DOCK4 HIF1A GBF1 ATR INHBB CASP8 ARHGAP35 RBM39 LRPPRC BMPR1A EGFR UBE3A ARID5B VPS13A MACF1 TNKS N4BP1 DMD PPIP5K2 SOS1 | 3.70e-08 | 856 | 155 | 21 | M4500 |
| Coexpression | GSE17721_12H_VS_24H_CPG_BMDC_DN | 3.15e-06 | 200 | 155 | 9 | M4133 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | HSPA4L RALGAPB GJC1 SYNC SKIL RBM39 RBM25 GCLC HPGD ATF7IP NFKBIA N4BP1 KIF3C MORC3 CHTOP GPRC5B SOS1 | 7.96e-06 | 822 | 155 | 17 | M6782 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | LCA5 ANO2 NEBL INHBB LRP1B LANCL2 P3H4 RGMA MAGI2 BMP1 HEPACAM KIF9 SPAG16 DNAH6 | 8.54e-06 | 574 | 155 | 14 | M39056 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | DOCK4 CASP8 ZBTB24 PHC2 GCLC ARID5B VPS13A N4BP1 MORC3 PPIP5K2 | 1.26e-05 | 300 | 155 | 10 | M8702 |
| Coexpression | GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP | 2.12e-05 | 194 | 155 | 8 | M10021 | |
| Coexpression | GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 2.37e-05 | 197 | 155 | 8 | M8980 | |
| Coexpression | KYNG_DNA_DAMAGE_UP | 3.14e-05 | 205 | 155 | 8 | M3961 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 3.95e-05 | 155 | 155 | 7 | M39246 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | DOCK4 VGLL3 NEBL USP25 EHD4 MAGI2 BMPR1A PHF20L1 ABCA5 PTPRO NFKBIA ARID5B VPS13A MACF1 LRBA PPIP5K2 | 4.91e-05 | 854 | 155 | 16 | M1533 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | DOCK4 VGLL3 NEBL USP25 EHD4 MAGI2 BMPR1A PHF20L1 ABCA5 PTPRO NFKBIA ARID5B VPS13A MACF1 LRBA PPIP5K2 | 7.76e-05 | 888 | 155 | 16 | MM1018 |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.58e-08 | 199 | 160 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.07e-07 | 193 | 160 | 8 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.92e-07 | 197 | 160 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 6.15e-07 | 198 | 160 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 6.63e-07 | 200 | 160 | 8 | ac0e023dbb383bbc46c5cc525431778be8f7ef46 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.63e-07 | 200 | 160 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 6.63e-07 | 200 | 160 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.92e-06 | 179 | 160 | 7 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.07e-06 | 180 | 160 | 7 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-06 | 184 | 160 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-06 | 184 | 160 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-06 | 184 | 160 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.41e-06 | 188 | 160 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.87e-06 | 195 | 160 | 7 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 6.87e-06 | 195 | 160 | 7 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 7.11e-06 | 196 | 160 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 7.35e-06 | 197 | 160 | 7 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 7.59e-06 | 198 | 160 | 7 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.59e-06 | 198 | 160 | 7 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.59e-06 | 198 | 160 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 7.59e-06 | 198 | 160 | 7 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.59e-06 | 198 | 160 | 7 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.54e-05 | 147 | 160 | 6 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.79e-05 | 151 | 160 | 6 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-05 | 157 | 160 | 6 | d85a2f56ae313baa9738e81d2756ce1fe1ba50db | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.24e-05 | 176 | 160 | 6 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 176 | 160 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-05 | 179 | 160 | 6 | 8f9e538c822940785130297712b75131812a4603 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.80e-05 | 180 | 160 | 6 | cf7d8bf9eee2dfab2c8a6780e296b05ad42041bf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.95e-05 | 181 | 160 | 6 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|kidney / Disease (COVID-19 only), tissue and cell type | 5.26e-05 | 183 | 160 | 6 | 3c4153479fc4ab2d073d92cee120480015555914 | |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.59e-05 | 185 | 160 | 6 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-05 | 185 | 160 | 6 | 2a8104f610fa5ce618f8105521616722462a0d42 | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.11e-05 | 188 | 160 | 6 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 6.29e-05 | 189 | 160 | 6 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.29e-05 | 189 | 160 | 6 | b4b93bd10b7e3cc16e54ff73beac230f519c010a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-05 | 190 | 160 | 6 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-05 | 190 | 160 | 6 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-05 | 190 | 160 | 6 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.67e-05 | 191 | 160 | 6 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.67e-05 | 191 | 160 | 6 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.67e-05 | 191 | 160 | 6 | 0965f621ebcd92ccdeb21cc27022180ce3cfe910 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.87e-05 | 192 | 160 | 6 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.87e-05 | 192 | 160 | 6 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.07e-05 | 193 | 160 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-05 | 193 | 160 | 6 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.07e-05 | 193 | 160 | 6 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.07e-05 | 193 | 160 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.07e-05 | 193 | 160 | 6 | 52e918884877b6659cdca0496390e440f73694a9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-05 | 194 | 160 | 6 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-05 | 194 | 160 | 6 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-05 | 194 | 160 | 6 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-05 | 194 | 160 | 6 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 7.48e-05 | 195 | 160 | 6 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.48e-05 | 195 | 160 | 6 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-05 | 195 | 160 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.69e-05 | 196 | 160 | 6 | 7cbb19108b4553ef60ef5c230a29de1662c02efe | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.69e-05 | 196 | 160 | 6 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 7.69e-05 | 196 | 160 | 6 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.69e-05 | 196 | 160 | 6 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.69e-05 | 196 | 160 | 6 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | Mild-CD4+_T_activated|World / Disease group and Cell class | 7.69e-05 | 196 | 160 | 6 | 417b4fc2e4388f34c410576131b02936f93e46b6 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.91e-05 | 197 | 160 | 6 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | mild-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.91e-05 | 197 | 160 | 6 | 39800e6e83f2d333b753d121c7aeb2912b91faa2 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-Treg|ICU-SEP / Disease, condition lineage and cell class | 7.91e-05 | 197 | 160 | 6 | c3ee2d522fbfe67069ddba2d1abfc4f5ca230c26 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-05 | 198 | 160 | 6 | 1378c6d4ceb84b42fdd6556be3296df7a8059e6e | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-Treg|ICU-NoSEP / Disease, condition lineage and cell class | 8.14e-05 | 198 | 160 | 6 | 1ed4dfe5565328cb0f7ef31e6b2f67dfbdf3e2ac | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.14e-05 | 198 | 160 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | BAL-Severe|BAL / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.14e-05 | 198 | 160 | 6 | 454aee3f4fe6d0beeccc55200b4495f4f9b44feb | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.36e-05 | 199 | 160 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 8.36e-05 | 199 | 160 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.60e-05 | 200 | 160 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 8.60e-05 | 200 | 160 | 6 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.60e-05 | 200 | 160 | 6 | 7595eb2a8af3de879ecaa71f3d96f890e13b59ce | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.28e-04 | 135 | 160 | 5 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-Treg|ICU-SEP / Disease, Lineage and Cell Type | 1.78e-04 | 145 | 160 | 5 | ee99b58462f955b96d036aa67e343db047d66f64 | |
| ToppCell | severe_COVID-19-Treg|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.15e-04 | 151 | 160 | 5 | bef8f31d5c4345a346fcf15db0fa36265ac304e7 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.36e-04 | 154 | 160 | 5 | 9200e2f1783e54cbc5dfc3b485b57c761af74a46 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-04 | 155 | 160 | 5 | 90e629681a72baacc7981b82883866a487638dbc | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.50e-04 | 156 | 160 | 5 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 157 | 160 | 5 | 5d08ff0ba9d3df9cc30f13cab2d2b395ea6f3446 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 157 | 160 | 5 | ad9c9b7dfeee3ae46e7e593c51a0407df12195b4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-04 | 158 | 160 | 5 | 7960337d87afecf2692ab65e5991f052ceddfacc | |
| ToppCell | IPF-Epithelial-Ionocyte|IPF / Disease state, Lineage and Cell class | 2.81e-04 | 160 | 160 | 5 | d65d19f4fae60836bfd4303a1bb7de34e9d83e35 | |
| ToppCell | IPF-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 2.89e-04 | 161 | 160 | 5 | f1cd5c938cdc08ad8995371b72493850a6cf277a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-04 | 162 | 160 | 5 | c399b9e4854916a59f5cae2d8dbf19660f8759be | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-04 | 162 | 160 | 5 | a291248b693c771845174393934a782f1d8bd7ce | |
| ToppCell | normal-na-Lymphocytic_T-T4_reg-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.06e-04 | 163 | 160 | 5 | 43887e7687fc6367efac0c1f56a9534b06f47b7f | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 163 | 160 | 5 | 132aece9c79499b4bb3c2bde68d3d7202e1d8772 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.33e-04 | 166 | 160 | 5 | 9fd9de82f98b9acdaa59ac98fb9664161514aec0 | |
| ToppCell | moderate-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.33e-04 | 166 | 160 | 5 | c3835b424c63bf11a4e2c47635dc3787fc4a637a | |
| ToppCell | mild-Lymphocytic-CD4_T_cells_3|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.33e-04 | 166 | 160 | 5 | f8f8423423d72f0ea0266b59126abb27beb23094 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 3.52e-04 | 168 | 160 | 5 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 3.52e-04 | 168 | 160 | 5 | 00646601548b0fee42ae16bfa5e93603bc7c5129 | |
| ToppCell | droplet-Marrow-BM-30m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 169 | 160 | 5 | 8e7a30eb546fc6fa184ebb76f54b74b278005a84 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 169 | 160 | 5 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.72e-04 | 170 | 160 | 5 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-like-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.82e-04 | 171 | 160 | 5 | ca2775a17b5c339c480a963953b6fa2b0731f24d | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 3.82e-04 | 171 | 160 | 5 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | facs|World / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 171 | 160 | 5 | 5bcb96ed7fc15548f2dc9cf47482f890640cb39c | |
| Disease | Blindness, Monocular | 7.68e-05 | 3 | 150 | 2 | C0750958 | |
| Disease | Blindness, Acquired | 7.68e-05 | 3 | 150 | 2 | C0339730 | |
| Disease | Amaurosis | 7.68e-05 | 3 | 150 | 2 | C0376288 | |
| Disease | Blindness, Legal | 7.68e-05 | 3 | 150 | 2 | C0271215 | |
| Disease | Blindness, Hysterical | 7.68e-05 | 3 | 150 | 2 | C0221473 | |
| Disease | Blindness, Transient | 7.68e-05 | 3 | 150 | 2 | C0155003 | |
| Disease | Blindness | 7.68e-05 | 3 | 150 | 2 | C0456909 | |
| Disease | Blindness both eyes NOS (disorder) | 7.68e-05 | 3 | 150 | 2 | C1879328 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 1.04e-04 | 91 | 150 | 5 | EFO_0004611, EFO_0005271 | |
| Disease | Malignant neoplasm of breast | HIF1A ANK2 KALRN CYP24A1 SHMT1 CASP8 HELQ BMP1 EGFR NFKBIA ACCS ZNF75A MACF1 LRBA DMD | 3.94e-04 | 1074 | 150 | 15 | C0006142 |
| Disease | muscular atrophy (biomarker_via_orthology) | 4.27e-04 | 29 | 150 | 3 | DOID:767 (biomarker_via_orthology) | |
| Disease | lung cancer (is_implicated_in) | 5.60e-04 | 74 | 150 | 4 | DOID:1324 (is_implicated_in) | |
| Disease | colon cancer (is_implicated_in) | 8.13e-04 | 36 | 150 | 3 | DOID:219 (is_implicated_in) | |
| Disease | Graves Disease | 9.03e-04 | 9 | 150 | 2 | C0018213 | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 9.03e-04 | 9 | 150 | 2 | C0085548 | |
| Disease | Cancer of Nasopharynx | 9.03e-04 | 9 | 150 | 2 | C0238301 | |
| Disease | egg allergy measurement | 9.03e-04 | 9 | 150 | 2 | EFO_0007018 | |
| Disease | nephritis (biomarker_via_orthology) | 1.37e-03 | 11 | 150 | 2 | DOID:10952 (biomarker_via_orthology) | |
| Disease | atopic dermatitis (implicated_via_orthology) | 1.37e-03 | 11 | 150 | 2 | DOID:3310 (implicated_via_orthology) | |
| Disease | bronchopulmonary dysplasia (biomarker_via_orthology) | 1.64e-03 | 12 | 150 | 2 | DOID:11650 (biomarker_via_orthology) | |
| Disease | pulmonary emphysema (implicated_via_orthology) | 1.93e-03 | 13 | 150 | 2 | DOID:9675 (implicated_via_orthology) | |
| Disease | lung adenocarcinoma (is_implicated_in) | 2.00e-03 | 49 | 150 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | Intellectual Disability | 2.11e-03 | 447 | 150 | 8 | C3714756 | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 2.12e-03 | 50 | 150 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | L2 Acute Lymphoblastic Leukemia | 2.12e-03 | 50 | 150 | 3 | C0023453 | |
| Disease | Neoplasm of lung | 2.24e-03 | 14 | 150 | 2 | cv:C0024121 | |
| Disease | Lung cancer | 2.24e-03 | 14 | 150 | 2 | cv:C0242379 | |
| Disease | LUNG CANCER | 2.24e-03 | 14 | 150 | 2 | 211980 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 2.37e-03 | 52 | 150 | 3 | C0023452 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 2.58e-03 | 15 | 150 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | Schizoaffective disorder-bipolar type | 2.94e-03 | 16 | 150 | 2 | EFO_0009965 | |
| Disease | vision disorder | 2.94e-03 | 16 | 150 | 2 | MONDO_0021084 | |
| Disease | gliosarcoma | 2.94e-03 | 16 | 150 | 2 | C0206726 | |
| Disease | adverse effect, response to xenobiotic stimulus | 3.40e-03 | 59 | 150 | 3 | EFO_0009658, GO_0009410 | |
| Disease | Alzheimer disease | 3.47e-03 | 485 | 150 | 8 | MONDO_0004975 | |
| Disease | Brain Ischemia | 3.56e-03 | 60 | 150 | 3 | C0007786 | |
| Disease | Cerebral Ischemia | 3.56e-03 | 60 | 150 | 3 | C0917798 | |
| Disease | Malignant neoplasm of endometrium | 3.72e-03 | 18 | 150 | 2 | C0007103 | |
| Disease | Myeloid Leukemia | 3.72e-03 | 18 | 150 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 3.72e-03 | 18 | 150 | 2 | C0023466 | |
| Disease | Carcinoma in situ of endometrium | 3.72e-03 | 18 | 150 | 2 | C0346191 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 3.74e-03 | 61 | 150 | 3 | C1961102 | |
| Disease | Adenocarcinoma of lung (disorder) | 4.13e-03 | 206 | 150 | 5 | C0152013 | |
| Disease | cerebral infarction (is_marker_for) | 4.15e-03 | 19 | 150 | 2 | DOID:3526 (is_marker_for) | |
| Disease | Cholecystitis | 4.15e-03 | 19 | 150 | 2 | HP_0001082 | |
| Disease | pulmonary hypertension (is_marker_for) | 4.28e-03 | 64 | 150 | 3 | DOID:6432 (is_marker_for) | |
| Disease | Prostatic Neoplasms | 4.38e-03 | 616 | 150 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 4.38e-03 | 616 | 150 | 9 | C0376358 | |
| Disease | household income | 4.72e-03 | 304 | 150 | 6 | EFO_0009695 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PDVIITEEYTNEKEM | 101 | Q8WWZ7 | |
| YDNDLNPVMDAKAQE | 1991 | Q96L91 | |
| ELADFMEQLTPIEKY | 2151 | Q96L91 | |
| DSEEYEAMPVEVKLL | 386 | Q53H12 | |
| QKDNPAEYASLMEIL | 536 | P83436 | |
| MDEYDEDKNPSGIIN | 86 | Q96QU6 | |
| QNDEAVAPLMKYLDE | 886 | O94812 | |
| SEDEDNAKPMNYDEK | 501 | Q58F21 | |
| LANYMPKDDREAQSI | 226 | Q10567 | |
| LIELNMDSPEELQSY | 346 | Q9H9F9 | |
| EYKTPDELQKAVEEM | 1186 | P11532 | |
| DSPEDDMNDRKLLYQ | 321 | Q9NQ90 | |
| EYNFLKMEPQEVESL | 246 | P13497 | |
| PLTKEQLYQQAMEEA | 606 | O75175 | |
| KLFVPYTEMEIENEQ | 526 | P24386 | |
| EAMLEAPYKKEEDEQ | 11 | Q86U06 | |
| YPLITKEDINAIEME | 256 | P49756 | |
| DIEAMLEAPYKKDEN | 6 | Q14498 | |
| EDKMNLYPIDVEIID | 111 | Q9Y5G6 | |
| QKVTDDMYAEQTENP | 681 | Q2TAL8 | |
| KEDEDYMPIKNTNQD | 396 | Q8WUA2 | |
| TLVDEQPLENYLDME | 61 | P0DJD9 | |
| MDVPVSDLAENDEIY | 2906 | Q01484 | |
| KMQDLPEESSLEYQQ | 3756 | Q01484 | |
| IRNPEDAEQYIEKML | 1351 | Q8N7Z5 | |
| PAEQSLDMEEKDYSE | 56 | Q9H4G0 | |
| NTKIADEYMIPIENL | 541 | Q9NZR2 | |
| VYSQPEELKEQMDDT | 276 | Q86UL8 | |
| AEEDKMPPYDEQTQA | 351 | P14314 | |
| MTEPIDEYCVQQLKE | 386 | Q58FF7 | |
| MSEPIDEYCVQQLKE | 421 | Q58FF6 | |
| DDQQLEEVPLYNDVM | 421 | Q16665 | |
| KDELEMQQDEENLPY | 81 | Q9HCE5 | |
| DDEYNIVKRDVPNMI | 386 | P09529 | |
| DQETLTEMVKPSIDY | 281 | Q9NS86 | |
| LQEYEMEVVPNKDFL | 4706 | Q5CZC0 | |
| QPILESALEKNMENY | 446 | O14782 | |
| LQPVDSKIQEIEYME | 276 | Q8N5G2 | |
| SEQIYEDPMQKITDL | 1996 | Q9Y6V0 | |
| EDPMQKITDLQKEFY | 2001 | Q9Y6V0 | |
| KQERMDQIAPESDYS | 236 | Q14149 | |
| PEVVNYDQISDKTDM | 451 | Q9H1R3 | |
| EEIQMADYISKNVPA | 466 | O14511 | |
| PILNSYLENMEVDVD | 536 | P48506 | |
| KMNYLVLEENVDNDP | 2176 | O60229 | |
| ELNPEEGEMVEEKYQ | 1976 | O94854 | |
| YEEMKAEQENQELPD | 1016 | P50851 | |
| YPIQNMDKLQGEEEE | 446 | Q86VQ0 | |
| IPELNEKEEAYNSLM | 1311 | P42704 | |
| NDKQYLNHMDEVPEE | 256 | Q96PP9 | |
| FPEVKAMQEQLENYD | 356 | Q9H223 | |
| NLQMLPESEDEESYD | 276 | P25963 | |
| EPQLRMKNNEEAEDY | 351 | P00451 | |
| NLKNAEIEPDDYFMS | 331 | Q9Y2C4 | |
| TTEPAINEKYDAERM | 341 | Q9HAQ2 | |
| DLPIDLEEQTMGKYN | 906 | Q9BZA7 | |
| PDEILEDDMEYLTQA | 376 | C9JSJ3 | |
| TLVDEQPLENYLDME | 61 | P0DJD8 | |
| NPVQLDDFDAYIKDM | 916 | Q16827 | |
| YLMDNPTFAEDEELQ | 556 | O75400 | |
| EEDVQLPRAYMENKA | 321 | Q9NZH0 | |
| IYVPMEDDIHEQNSK | 151 | Q8NFZ3 | |
| DMDDVVDADEYLIPQ | 1006 | P00533 | |
| YDPIRMEFENKEDLS | 161 | P57076 | |
| VEMDTDQLKLYEEPL | 281 | Q13535 | |
| MIKSDNEEYFIEPLE | 171 | O15072 | |
| DRIYDDMPDIEKTAN | 2386 | Q9C0G6 | |
| DMPDIEKTANVLQDY | 2391 | Q9C0G6 | |
| APMADSLQEFKDYIE | 3791 | Q9C0G6 | |
| QLKEKDIMDLYNQPE | 86 | Q9UHA7 | |
| EYSIQTMEPDNLELI | 216 | Q9NPB8 | |
| LPYDQSDEESMNIVL | 231 | Q9UHW5 | |
| ERIKEEMSKDQPDYA | 196 | Q92608 | |
| EDAELFMSLYDPNKQ | 236 | Q92608 | |
| SLYDKIMDQQRLEPE | 1301 | Q8N1I0 | |
| RKYDIQATDNEPVEM | 481 | Q07973 | |
| YPEMELESDKENKEQ | 141 | P36383 | |
| DQEESEQMQDKLEYL | 2966 | Q8N3K9 | |
| NQIRTLMEEDPEKYE | 151 | Q99807 | |
| MLKRLAENPEYENEK | 686 | Q9BYX4 | |
| RYMAPEVLDESLNKN | 406 | P36894 | |
| MNDYKLEEDPVTKER | 1 | Q3B7I2 | |
| VETDSEEQPYLEMDL | 371 | Q14790 | |
| TSPLENMDYIKDKEE | 56 | Q6VMQ6 | |
| LPYLVEVFTNDKMEE | 1466 | Q9Y4F3 | |
| YHAIKNEEIVMPEEQ | 876 | Q92538 | |
| NLSDEMYEILSNLPE | 1601 | Q03164 | |
| YMDQNDDRLKPEADT | 281 | Q14CZ8 | |
| AQVDDLEQKYMQLPE | 121 | Q8TDG4 | |
| LYEEENEPDAQMLEI | 1121 | Q7Z5N4 | |
| RSYEDDDDMDLQPNK | 166 | Q9BTE3 | |
| AEKQQSPEVLDYMLQ | 1386 | Q5THK1 | |
| TLVDEQPLENYLDME | 61 | P0DJD7 | |
| EKKEDYNETAPMLEQ | 296 | A8MW92 | |
| VSQELDPDLYKQMEK | 176 | Q05084 | |
| LESIEKEENMGQYIE | 191 | P15428 | |
| MLAQPLKDSDVEVYN | 21 | P34896 | |
| LVMEEAPESYKNVTD | 466 | Q9Y3I0 | |
| LSNKKIYQEEEMPES | 51 | P35269 | |
| EALYIEEAMQPDEAL | 81 | Q9H7C4 | |
| LMAESRQDLEEEYEP | 331 | Q9H7C4 | |
| PEDLAMSYEESQDLQ | 296 | Q6NW40 | |
| MEEYQRAELEEDPIL | 161 | Q9UN30 | |
| EQAVIEKPMEDEDRY | 416 | Q96JX3 | |
| EKMYENVLNESPVQL | 66 | Q6UWF3 | |
| EYEVPEAAQLALEQM | 176 | Q9UHX1 | |
| TLENPYMLNEEETTE | 476 | Q4G0N8 | |
| VSYPDVSLEEQEKMD | 451 | P12757 | |
| GDLMKTEDEYDQLEQ | 651 | Q7Z7B0 | |
| YTDETQPEMDLFLKD | 306 | Q7Z494 | |
| YLANDMEEDDEAPKQ | 166 | P0DUX0 | |
| YLANDMEEDDEAPKQ | 166 | P0DTA3 | |
| YLANDMEEDDEAPKQ | 166 | P0DUD1 | |
| PFDTQVTDIDYMEDK | 381 | P14410 | |
| YQEESTMKVDEDPDL | 586 | Q96JS3 | |
| EEKEEQMRLPSADVY | 561 | Q07889 | |
| CVDQKVYQAEMDELP | 226 | Q96B86 | |
| MDAVVKPRNEEENIY | 1091 | Q9NRY4 | |
| YDIDVEVDDPLKAQM | 406 | Q92925 | |
| PQEIFEYLMDRLEKE | 241 | P55201 | |
| TEDDKLPAMADYIAN | 611 | Q14865 | |
| RYEIPDTQMADEKQL | 121 | P78348 | |
| EAYVEDPEDLKNEEM | 741 | Q96JQ2 | |
| LDAELDAYMAQTDPE | 231 | Q9Y3Y2 | |
| SPAQKDLYRDVMLEN | 26 | Q8N8J6 | |
| SEMEEPYLQESKEEG | 621 | Q8IXK0 | |
| KMAIVESDPEEENYK | 1811 | Q96RL7 | |
| NEPLNEVLEMDKDYT | 451 | Q05086 | |
| DMEDHQDQEYIKPRL | 196 | Q14CS0 | |
| NKDERYDHLDPTEME | 721 | O95757 | |
| YLANDMEEDDEAPKQ | 166 | P0DUX1 | |
| YLANDMEEDDEAPKQ | 166 | A0A494C0Z2 | |
| NDKMEAESIYINDPT | 556 | Q6ZVD7 | |
| YLANDMEEDDEAPKQ | 166 | P0DUD3 | |
| YLANDMEEDDEAPKQ | 166 | P0DUD4 | |
| YLANDMEEDDEAPKQ | 166 | P0DUD2 | |
| DPDEKITYRDVMLEN | 26 | Q9NYW8 | |
| YLQSDDEMELEETEP | 376 | Q92791 | |
| ALENPVKYAEDNMEQ | 246 | Q8IV42 | |
| LAPEDKEYQSVEEEM | 1111 | O95271 | |
| LEPAQKNLYQDVMLE | 21 | Q14586 | |
| PDVYTQIMLLENENK | 151 | Q8N0X2 | |
| LEMIKPEEVNLEEYE | 851 | Q9UHP3 | |
| YFAEMDPDLEKQEES | 51 | Q8IWV7 | |
| DSEQDKEQSNPYMVL | 1186 | O75116 | |
| NMYVLLPENDLSEIE | 236 | O75635 | |
| QDYLLPEAEEITMIS | 2031 | O00507 | |
| QMDQSYKPDENEVRT | 366 | P31939 | |
| YDDIENFPLSELMTE | 1351 | Q86X10 | |
| QNAEKTMQITEEPEY | 746 | Q8NB14 | |
| SREEEMPVEKDENYD | 226 | O43167 | |
| PNDYEKDNMKILTFD | 226 | Q9NYT6 | |
| NVYLKFSEMDAPLED | 196 | Q9HBG4 | |
| MENSLILEDPFEYND | 106 | P0CI00 | |
| MENSLILEDPFEYND | 106 | P0CH99 | |
| KEEEQLSYDDPNRKM | 526 | Q86WT1 | |
| YLANDMEEDDEAPKQ | 166 | A0A494C191 | |
| DPEQKITYRDVMLEN | 26 | P17014 | |
| VDITEVPDFNKMYEL | 61 | P83876 | |
| IMLYEDPNKDLSSEE | 871 | O43314 | |
| LDPTQKALYNDVMQE | 11 | Q96N20 | |
| LQPTETESEDKYMKD | 2571 | Q9BXT5 | |
| EEEEKDQPAEMEYLN | 71 | A8MV65 | |
| EYGNLKQEVSEEMEP | 191 | O43309 | |
| KPRMLEDSDEQLDYT | 301 | Q6P2D8 | |
| EDSDEQLDYTVLPMK | 306 | Q6P2D8 | |
| QALELLSEMEENEPY | 206 | O75204 | |
| VIMLYEDNTQDPLSE | 886 | Q6PFW1 | |
| IEQADPENMVENEYK | 471 | Q96FV9 | |
| SPAQKDLYRDVMLEN | 26 | Q9BS31 | |
| PDIKETTEEMEYNIL | 336 | O75113 | |
| DMYSNQDPENKDLLE | 1096 | Q01538 | |
| DQVFYKPVIEDLSME | 26 | O76041 |